Literature DB >> 28989442

Outbreak column 18: The undervalued work of outbreak: prevention, preparedness, detection and management.

Evonne T Curran1, Catherine E Dalziel2.   

Abstract

There are oft-quoted studies which advise that between 1% and 10% of healthcare-associated infections (HAIs) present as healthcare-associated outbreaks (HAOs). Examination of these studies showed they lacked validity due to a low sensitivity to detect HAO, and because they pre-date both advanced healthcare systems and the emergence of recent nosocomial pathogen challenges. The accepted inference: that as there are so few HAOs the focus of surveillance programmes should be on endemic and not epidemic infections (outbreaks), is therefore called into question. Current estimates of HAI burden are derived from Point Prevalence Surveys (PPS) which are neither designed to nor are capable of detecting HAOs. We considered the extensive Infection Prevention and Control Team (IPCT) work to prevent and prepare for perennial and novel HAOs and suggest that at present this endeavour is largely unseen, underestimated and undervalued. Any HAI burden estimate needs to comprise a more complete HAI summary than PPS data. This can only be done with a more inclusive surveillance system that has a wider focus than just prevalent infections. There is a real risk of redirection of the IPCT resource from outbreak prevention and preparedness work towards HAI that are counted: such a change could only further increase HAO risks.

Entities:  

Year:  2015        PMID: 28989442      PMCID: PMC5074162          DOI: 10.1177/1757177415599592

Source DB:  PubMed          Journal:  J Infect Prev        ISSN: 1757-1782


  21 in total

1.  Editorial: not so nosocomial anymore: the growing threat of community-acquired Clostridium difficile.

Authors:  Daniel A Leffler; J Thomas Lamont
Journal:  Am J Gastroenterol       Date:  2012-01       Impact factor: 10.864

Review 2.  Burden of norovirus in healthcare facilities and strategies for outbreak control.

Authors:  A Kambhampati; M Koopmans; B A Lopman
Journal:  J Hosp Infect       Date:  2015-02-04       Impact factor: 3.926

3.  Results from the second Scottish national prevalence survey: the changing epidemiology of healthcare-associated infection in Scotland.

Authors:  J Reilly; S Cairns; S Fleming; D Hewitt; R Lawder; C Robertson; W Malcolm; D Nathwani; C Williams
Journal:  J Hosp Infect       Date:  2012-09-28       Impact factor: 3.926

4.  Evaluating the quality of outbreak reports on health care-associated infections in São Paulo, Brazil, during 2000-2010 using the ORION statement findings and recommendations.

Authors:  Amanda Luiz Pires Maciel; Denise Brandão de Assis; Geraldine Madalosso; Maria Clara Padoveze
Journal:  Am J Infect Control       Date:  2014-04       Impact factor: 2.918

5.  Lessons from recent nosocomial epidemics.

Authors:  C L Richards; W R Jarvis
Journal:  Curr Opin Infect Dis       Date:  1999-08       Impact factor: 4.915

Review 6.  Risk of transmission of carbapenem-resistant Enterobacteriaceae and related "superbugs" during gastrointestinal endoscopy.

Authors:  Lawrence F Muscarella
Journal:  World J Gastrointest Endosc       Date:  2014-10-16

7.  How frequent are outbreaks of nosocomial infection in community hospitals?

Authors:  R W Haley; J H Tenney; J O Lindsey; J S Garner; J V Bennett
Journal:  Infect Control       Date:  1985-06

8.  Comparison of endemic and epidemic nosocomial infections.

Authors:  W E Stamm; R A Weinstein; R E Dixon
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

Review 9.  Community-acquired Clostridium difficile infection: an increasing public health threat.

Authors:  Arjun Gupta; Sahil Khanna
Journal:  Infect Drug Resist       Date:  2014-03-17       Impact factor: 4.003

10.  Results from the first 12 months of the national surveillance of healthcare associated outbreaks in Germany, 2011/2012.

Authors:  Sebastian Haller; Tim Eckmanns; Justus Benzler; Kristin Tolksdorf; Hermann Claus; Andreas Gilsdorf; Muna Abu Sin
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.